Medirom Healthcare Technologies Inc. Announces New Stock Option Plan with Performance-Based Criteria for 2025

Reuters

06-30

Medirom Healthcare Technologies Inc. Announces New Stock Option Plan with Performance-Based Criteria for 2025

On June 26, 2025, Medirom Healthcare Technologies Inc. announced the approval of a new stock option allotment under its 2024 Equity Incentive Compensation Plan. The approved issuance includes 207,000 stock options for directors and statutory auditors, 87,000 for company employees, and 106,000 for external collaborators. These stock options are contingent upon the company's adjusted consolidated revenues surpassing JPY10 billion in any fiscal year between 2026 and 2028, excluding revenues from Digital Preventative Healthcare and Sales of Directly-Owned Salons. Additionally, holders must remain affiliated with Medirom or its subsidiaries to exercise their options, with certain exceptions for tenure expiration or retirement. The company anticipates recipients to formalize stock option agreements by July 7, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008983), on June 30, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2547060953"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2547060953\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2547060953?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-30 18:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2547060953","market":"us","top_or_hot":-1,"title":"Medirom Healthcare Technologies Inc. Announces New Stock Option Plan with Performance-Based Criteria for 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Medirom Healthcare Technologies Inc. Announces New Stock Option Plan with Performance-Based Criteria for 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        On June 26, 2025, Medirom Healthcare Technologies Inc. announced the approval of a new stock option allotment under its 2024 Equity Incentive Compensation Plan. The approved issuance includes 207,000 stock options for directors and statutory auditors, 87,000 for company employees, and 106,000 for external collaborators. These stock options are contingent upon the company's adjusted consolidated revenues surpassing JPY10 billion in any fiscal year between 2026 and 2028, excluding revenues from Digital Preventative Healthcare and Sales of Directly-Owned Salons. Additionally, holders must remain affiliated with Medirom or its subsidiaries to exercise their options, with certain exceptions for tenure expiration or retirement. The company anticipates recipients to formalize stock option agreements by July 7, 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008983), on June 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medirom Healthcare Technologies Inc. Announces New Stock Option Plan with Performance-Based Criteria for 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedirom Healthcare Technologies Inc. Announces New Stock Option Plan with Performance-Based Criteria for 2025\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-06-30 18:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Medirom Healthcare Technologies Inc. Announces New Stock Option Plan with Performance-Based Criteria for 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        On June 26, 2025, Medirom Healthcare Technologies Inc. announced the approval of a new stock option allotment under its 2024 Equity Incentive Compensation Plan. The approved issuance includes 207,000 stock options for directors and statutory auditors, 87,000 for company employees, and 106,000 for external collaborators. These stock options are contingent upon the company's adjusted consolidated revenues surpassing JPY10 billion in any fiscal year between 2026 and 2028, excluding revenues from Digital Preventative Healthcare and Sales of Directly-Owned Salons. Additionally, holders must remain affiliated with Medirom or its subsidiaries to exercise their options, with certain exceptions for tenure expiration or retirement. The company anticipates recipients to formalize stock option agreements by July 7, 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008983), on June 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRM","symbol_name":"MEDIROM Healthcare Technologies, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL4qyP19:1","article_id":"2547060953","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2547060953","pubTimestamp":1751278257,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"On June 26, 2025, Medirom Healthcare Technologies Inc. announced the approval of a new stock option allotment under its 2024 Equity Incentive Compensation Plan. The approved issuance includes 207,000 stock options for directors and statutory auditors, 87,000 for company employees, and 106,000 for external collaborators. These stock options are contingent upon the company's adjusted consolidated revenues surpassing JPY10 billion in any fiscal year between 2026 and 2028, excluding revenues from Digital Preventative Healthcare and Sales of Directly-Owned Salons. Additionally, holders must remain affiliated with Medirom or its subsidiaries to exercise their options, with certain exceptions for tenure expiration or retirement. The company anticipates recipients to formalize stock option agreements by July 7, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gen","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRM":"MEDIROM Healthcare Technologies, Inc.","BK4192":"特殊消费者服务"},"translate_title":"Medirom Healthcare Technologies Inc.宣布新的股票期权计划，其中包含2025年基于绩效的标准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRM":0.9},"content_text":"Medirom Healthcare Technologies Inc. Announces New Stock Option Plan with Performance-Based Criteria for 2025\n    \n\n        On June 26, 2025, Medirom Healthcare Technologies Inc. announced the approval of a new stock option allotment under its 2024 Equity Incentive Compensation Plan. The approved issuance includes 207,000 stock options for directors and statutory auditors, 87,000 for company employees, and 106,000 for external collaborators. These stock options are contingent upon the company's adjusted consolidated revenues surpassing JPY10 billion in any fiscal year between 2026 and 2028, excluding revenues from Digital Preventative Healthcare and Sales of Directly-Owned Salons. Additionally, holders must remain affiliated with Medirom or its subsidiaries to exercise their options, with certain exceptions for tenure expiration or retirement. The company anticipates recipients to formalize stock option agreements by July 7, 2025.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008983), on June 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}